Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Lloyd

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 29, 2016
Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label studyAlison Handley, Eric Lloyd, Andrew Roberts, et al.
Vaccine|September 7, 2024
Early onset of protection of the TAK-003 dengue vaccine: Data from the DEN-301 clinical trialEckhardt Petri, Shibadas Biswal, Eric Lloyd, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 27, 2015
Safety, tolerability, and efficacy of azilsartan medoxomil with or without chlorthalidone during and after 8 months of treatment for hypertensionMark S Kipnes, Alison Handley, Eric Lloyd, et al.
Pharmacotherapy|February 26, 2008
Greater immediate gastric acid suppression with lansoprazole 30 mg administered as a 2-minute intravenous bolus injection versus a 30-minute infusionDavid C Metz, John W Devlin, Majid Vakily, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 7, 2017
Comparison of long-term safety of fixed-dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazideJoel M Neutel, William C Cushman, Eric Lloyd, et al.
Journal of Child and Adolescent Psychopharmacology|March 1, 2022
A Long-Term, Open-Label Safety and Tolerability Study of Lisdexamfetamine Dimesylate in Children Aged 4-5 Years with Attention-Deficit/Hyperactivity DisorderAnn C Childress, Eric Lloyd, Steven A Johnson, et al.
Echocardiography (Mount Kisco, N.Y.)|October 4, 2020
Absent pulmonary valve or pulmonary atresia with intact ventricular septum: Which is it?Erin Nealon, Darren Berman, Daniel Rowland, et al.
Journal of Hypertension|January 15, 2016
Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetesWilliam B White, René H Cuadra, Eric Lloyd, et al.
The Journal of Rheumatology|March 17, 2009
Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with goutMichael A Becker, H Ralph Schumacher, Patricia A MacDonald, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 19, 2010
Tissue Doppler measurements correlate with central venous pressure in pediatric patients after cardiac surgeryChristopher P Learn, Andrew R Yates, Lisa Nicholson, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|January 29, 2016
Safety and tolerability of azilsartan medoxomil in subjects with essential hypertension: a one-year, phase 3, open-label studyAlison Handley, Eric Lloyd, Andrew Roberts, et al.
Vaccine|September 7, 2024
Early onset of protection of the TAK-003 dengue vaccine: Data from the DEN-301 clinical trialEckhardt Petri, Shibadas Biswal, Eric Lloyd, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 27, 2015
Safety, tolerability, and efficacy of azilsartan medoxomil with or without chlorthalidone during and after 8 months of treatment for hypertensionMark S Kipnes, Alison Handley, Eric Lloyd, et al.
Pharmacotherapy|February 26, 2008
Greater immediate gastric acid suppression with lansoprazole 30 mg administered as a 2-minute intravenous bolus injection versus a 30-minute infusionDavid C Metz, John W Devlin, Majid Vakily, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 7, 2017
Comparison of long-term safety of fixed-dose combinations azilsartan medoxomil/chlorthalidone vs olmesartan medoxomil/hydrochlorothiazideJoel M Neutel, William C Cushman, Eric Lloyd, et al.
Journal of Child and Adolescent Psychopharmacology|March 1, 2022
A Long-Term, Open-Label Safety and Tolerability Study of Lisdexamfetamine Dimesylate in Children Aged 4-5 Years with Attention-Deficit/Hyperactivity DisorderAnn C Childress, Eric Lloyd, Steven A Johnson, et al.
Echocardiography (Mount Kisco, N.Y.)|October 4, 2020
Absent pulmonary valve or pulmonary atresia with intact ventricular septum: Which is it?Erin Nealon, Darren Berman, Daniel Rowland, et al.
Journal of Hypertension|January 15, 2016
Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetesWilliam B White, René H Cuadra, Eric Lloyd, et al.
The Journal of Rheumatology|March 17, 2009
Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with goutMichael A Becker, H Ralph Schumacher, Patricia A MacDonald, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|June 19, 2010
Tissue Doppler measurements correlate with central venous pressure in pediatric patients after cardiac surgeryChristopher P Learn, Andrew R Yates, Lisa Nicholson, et al.
Pageof 3